SNX-5422 Mesylate

SNX-5422 mesylate · Esanex Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SNX-5422 Mesylate, covering 2012-05-17 to 2012-05-28. Get the full timeline:

Most recent: Clinical Trial Update: Safety And Pharmacology Study Of SNX-5422 Mesylate In Subjects With Refractory Solid Tumor Malignancies [Phase 1]